Product News
OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel
Enables ultra-low variant detection across a range of key measurable residual disease targets in acute myeloid leukaemia, including very large FLT3-ITDs
News & Articles
25
Selected Filters:
Industry News
NHS study confirms OGT’s CytoSure Constitutional v3 array has significantly higher reporting rate for developmental disorder research
Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure v3 vs traditional array design
Product News
FDA Grants De Novo Designation for OGT’s AML/MDS FISH Probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden
Industry News
OGT expands Cytocell sarcoma FISH probe range
Product News
OGT Simplifies Detection of Important Cancer Gene Variants
SureSeq myPanel™ NGS Custom Cancer Panels enable researchers to create bespoke probe panels from an expert-curated library
Product News
Oxford Gene Technology Enhances NGS Results from FFPE Samples
New SureSeq™ FFPE DNA Repair Mix delivers excellent sequencing data for confident variant calling from minimal DNA input
Industry News
OGT Helps Genetic Scientists Explore the Medical Exome
New whitepaper demonstrates how customizable, medically focused array designs complement NGS for clinical genetics research
Industry News
Oxford Gene Technology Expands Next Generation Sequencing Portfolio
New NGS products for streamlined sample prep and ovarian cancer research
Industry News
